Roles of dextrans on improving lymphatic drainage for liposomal drug delivery system

References

• Averbuch SD, Gaudiano G, Koch TH, Bachur NR. 1986. Doxorubicin-induced skin necrosis in the swine model: protection with a novel radical dimer. ed. p 88–94.
   Google Scholar
• Bartlett GR. (1959). Phosphorus assay in column chromatography. J Biol Chem, 234, 466–468.
   PubMed Web of Science ®Google Scholar
• Boman NL, Tron VA, Bally MB, Cullis PR. (1996). Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes. Cancer Chemotherapy and Pharmacology, 37, 351–355.
   PubMed Web of Science ®Google Scholar
• Eckelman WC, Karesh SM, Reba RC. (1975). New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. J Pharm Sci, 64, 704–706.
   PubMed Web of Science ®Google Scholar
• Forssen EA, Tokes ZA. (1983). Attenuation of dermal toxicity of doxorubicin by liposome encapsulation. Cancer Treat Rep, 67, 481–484.
   PubMedGoogle Scholar
• Fujiwara M, Baldeschwieler JD, Grubbs RH. (1996). Receptor-mediated endocytosis of poly(acrylic acid)-conjugated liposomes by macrophages. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1278, 59–67.
   PubMed Web of Science ®Google Scholar
• Gbadamosi JK, Hunter AC, Moghimi SM. (2002). PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEBS Letters, 532, 338–344.
   PubMed Web of Science ®Google Scholar
• Grant CW, Karlik S, Florio E. (1989). A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA. Magn Reson Med, 11, 236–243.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. (2008). Liposome research in drug delivery: the early days. J Drug Target, 16, 520–524.
   PubMed Web of Science ®Google Scholar
• Hawley AE, Davis SS, Illum L. (1995). Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Advanced Drug Delivery Reviews, 17, 129–148.
   Web of Science ®Google Scholar
• Kaur Chanchal D, Nahar M, Jain Narendra K. (2008). Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target, 16, 798–805.
   PubMed Web of Science ®Google Scholar
• Khato J, Priester ER, Sieber SM. (1982). Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats. Cancer Treat Rep, 66, 517–527.
   PubMedGoogle Scholar
• Liu M, Pan J, Yao M, Zhou GX, Lu WY. (2007). In vivo antitumor effect of folate stealth liposomes load with doxorubicin in HeLa229 carcinoma nude mice model. Chinese Journal of Pharmaceuticals, 38, 97–101.
   Google Scholar
• Ma YM, Lu WY, Jiang CY, Liu YC. (1997). Studies on two new lymph imaging agents and their clinical application. Advanced Drug Delivery Reviews, 24, 315–323.
   Web of Science ®Google Scholar
• Mathias CJ, Hubers D, Low PS, Green MA. (2000). Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjug Chem, 11, 253–257.
   PubMed Web of Science ®Google Scholar
• McLennan DN, Porter CJH, Charman SA. (2005). Subcutaneous drug delivery and the role of the lymphatics. Drug Discovery Today: Technologies, 2, 89.
   Google Scholar
• Moghimi M, Moein Moghimi S. (2008). Lymphatic targeting of immuno-PEG-liposomes: Evaluation of antibody-coupling procedures on lymph node macrophage uptake. J Drug Targeting, 16, 586–590.
   PubMed Web of Science ®Google Scholar
• Moghimi SM. (2003). Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration. FEBS Letters, 540, 241–244.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hawley AE, Christy NM, Gray T, Illum L, Davis SS. (1994). Surface Engineered Nanospheres with Enhanced Drainage into Lymphatics and Uptake by Macrophages of the Regional Lymph-Nodes. Febs Letters, 344, 25–30.
   PubMed Web of Science ®Google Scholar
• Oussoren C, Eling WMC, Crommelin DJA, Storm G, Zuidema J. (1998a). The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochimica et Biophysica Acta, Biomembranes, 1369, 159–172.
   Google Scholar
• Oussoren C, Storm G. (2001). Liposomes to target the lymphatics by subcutaneous administration. Advanced Drug Delivery Reviews, 50, 143–156.
   PubMed Web of Science ®Google Scholar
• Oussoren C, Velinova M, Scherphof G, van der Want JJ, van Rooijen N, Storm G. (1998b). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1370, 259.
   PubMed Web of Science ®Google Scholar
• Paik CH, Ebbert MA, Murphy PR, Lassman CR, Reba RC, Eckelman WC, Pak KY, Powe J, Steplewski Z, Koprowski H. (1983). Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride. J Nucl Med, 24, 1158–1163.
   PubMed Web of Science ®Google Scholar
• Pan H, Han L, Chen W, Yao M, Lu W. (2008). Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes. Journal of Controlled Release, 125, 228–235.
   PubMed Web of Science ®Google Scholar
• Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R, Blumhardt R. (1992). A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nuclear Medicine and Biology, 19, 539–547.
   Web of Science ®Google Scholar
• Rao DA, Robinson JR. (2008). Effect of size and surface properties of biodegradable PLGA-PMA: PLA:PEG nanoparticles on lymphatic uptake and retention in rats. Journal of Controlled Release, 132, e45–e47.
   Web of Science ®Google Scholar
• Schmid-Schonbein GW. 1990. Microlymphatics and lymph flow. Physiological Reviews, ed. p 987–1028.
   Google Scholar
• Slauson DO, Lay JC, Castleman WL, Neilsen NR. (1989). Influence of acute pulmonary interstitial Inflammation on kinetics of phagocytosis by alveolar macrophages. Inflammation FIELD Full Journal Title:Inflammation, 13, 429–441.
   Google Scholar
• Spiegel RJ. (1981). The acute toxicities of chemotherapy. Cancer Treat Rev, 8, 197–207.
   PubMed Web of Science ®Google Scholar
• Strand SE, Bergqvist L. (1989). Radiolabeled colloids and macromolecules in the lymphatic system. Crit Rev Ther Drug Carrier Syst, 6, 211–238.
   PubMed Web of Science ®Google Scholar
• Swartz MA. (2001). The physiology of the lymphatic system. Advanced Drug Delivery Reviews, 50, 3–20.
   PubMed Web of Science ®Google Scholar
• Trubetskoy VS, Whiteman KR, Torchilin VP, Wolf GL. (1998). Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood. J Control Release, 50, 13–19.
   PubMed Web of Science ®Google Scholar
• van Rooijen N. (2008). Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages. J Drug Target, 16, 529–534.
   PubMed Web of Science ®Google Scholar
• Yang GC, Brooks JJ, Roberts S, Gupta PK. (1993). The detection of acquired immunodeficiency syndrome-associated Kaposi sarcoma cells in pleural effusion by CD34 immunostain. Cancer, 72, 2260–2265.
   PubMed Web of Science ®Google Scholar